Use of corticotropin releasing factor antagonists and related compositions
US6777404B2 · kind B2 · utility
13Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2003 |
| Grant date | Aug 17, 2004 |
| Priority date | — |
| Expiry date | Apr 15, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods of achieving a therapeutic effect including, the treatment or prevention of Syndrome X in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor (CRF) antagonist alone or together with a glucocorticoid receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.